Category Archives: Finanzen/Wirtschaft

Finanzen/Wirtschaft Pressemitteilungen

Cadmium Pigments Market Emerging Trends and Growth Factors Analysis over 2019 – 2025

19. August 2019 – 17:37

The report presenting a comprehensive exploration of the Worldwide Cadmium Pigments Market encloses the rate of growth of the market over the projected duration. Providing a concise synopsis, the report determines the valuation and size of the Wooden Decking industry in the near future.

Based on region Asia Pacific is expected to hold largest share in the cadmium pigments market over the forecast timeframe. Demand of cadmium pigments is expected to remain high in China, India, Japan, etc. The market is expected to flourish as the application of cadmium pigment is increasing in batteries and with growing automobile demand it will also escalate. North America is expected to show sluggish growth rate due to matured construction as well as automobile demand. In Europe the market growth rate is expected to remain low due to implementation of various regulations regarding its negative impact on the human health.

Request for table of content of this Report @
https://www.gminsights.com/request-toc/upcoming/4004

Cadmium pigments find their vast application in plastics as these have high opacity, tinting strength and give good coloring. The pigments are not soluble in organic solvents and have resistance to alkalis and will retain color for the life of plastic. Pigments are majorly added in plastics at 0.01 to 0.07%by weight. In specialized paints and industrial coatings this concentration ranges between 10 to 15 %. These are used majorly in complex polymers such as nylon, polycarbonates, silicone resins, acrylonitrile butadiene styrene and other thermoplastic polymers that are processed at high temperatures. These engineered polymers which use cadmium pigments are used in manufacturing electricity cables, gas pipes & fittings, motor vehicles radiators, etc.

On the basis of type, cadmium pigments market is segmented into cadmium yellow, cadmium orange, cadmium red, cadmium green, etc. These are different types of pigments are being used to impart various colors in variety of products. These types of pigments are used by artists as these are preferred choice for water and oil colors. In various coil coatings owing to nature of application area orange, bright yellow and red color is not achieved with using other pigments while it can be achieved by using cadmium pigments as they have excellent lightfastness.

Based on application, cadmium pigments market is classified into industrial paints, ceramics & glass, plastics, nylon, HDPE, acrylonitrile butadiene styrene (ABS), silicone resins, polycarbonate and others. The others include paper, rubber and inks although their share is less in the overall consumption. Rising demand of aesthetics in residential sector has increased the demand of construction products with large variety of colors and these will escalate the demand of the cadmium pigments. Due to ability to retain color and impart corrosion resistance the product is also preferred choice for industrial coatings as well. Inquiry Before Buying This Report @
https://www.gminsights.com/inquiry-before-buying/4004

The ability to withstand high temperatures makes cadmium pigments suitable to be used for ceramics and glass products. These are used for porcelain enamels, ceramics glazes and for various color ranges for glasses. Adverse effects of cadmium pigments on various body parts such as kidneys and lungs will, and regulations implemented for limiting their used in various plastics will act as a restraint for the cadmium pigments market growth. Fluctuations in raw material prices will also hinder the product market growth rate.

Various companies in the cadmium pigments market are investing substantially in the R&D sector to develop the bio-based cadmium pigments as there are many regulations implemented in developed economies regarding their environmental degradation caused by it. Market players are trying to expand their penetration to regions such as Middle East, Africa and Latin America, etc. Some of the prominent players present across the market are Proquimac, Huntsman Corporation, James M. Brown Ltd., Rockwood Pigments, Hunan Jufa Technology, Carl Schlenk, Clariant, Chemonova, BASF, LANXESS, etc.

About GMI

GMI, Inc., headquartered in Delaware, U.S., is a Worldwide market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Arun Hegde
Corporate Sales, USA
Worldwide Market Insights, Inc.
Phone:1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com/          

Permalink | Kommentare deaktiviert für Cadmium Pigments Market Emerging Trends and Growth Factors Analysis over 2019 – 2025
Finanzen/Wirtschaft

FXGM Erfahrungen 2019

8. Juli 2019 – 21:48

FXGM ist ein von CySEC regulierter Devisenbroker mit Sitz in Nikosia, Zypern. Neben dem regulären Devisenhandel bieten sie auch Dienstleistungen von persönlichen Kundenbetreuern, spezielle Marktanalysetools und eine 100%ige Investitionsversicherung an, bei der Händler Schutz für ihre ersten fünf Geschäfte erhalten. Händler können die Versicherung zu besonderen Bedingungen nutzen, aber das hat keinen Einfluss auf den Service, den dieser Forex-Broker bietet.

FXGM Review wird Händlern einen vollständigen Überblick über diesen Broker geben, einschließlich Kontoarten, Spezialsoftware, Funktionen, Tools, Kundensupport und Bankmethoden. Stellen Sie sicher, dass Sie die FXGM Broker Rezension lesen, bevor Sie eine Einzahlung tätigen und mit dem Handel beginnen.

FXGM

FXGM Geschichte & CySEC Probleme

FXGM wurde bereits 2010 unter einem anderen Markennamen gegründet – es hieß BForex. Sie fragen sich vielleicht, warum sollte ein erfolgreiches Forex-Unternehmen seinen Markennamen in einen neuen ändern wollen? Und Sie werden Recht haben, es gibt keine Gründe dafür, wenn Sie ein legitimes Unternehmen führen. Dies war bei BForex jedoch nicht der Fall.

FXGM Bonus-Überprüfung

FXGM ist eine Marke von Depaho Ltd – einer zypriotischen Investmentgesellschaft, die 2011 gegründet wurde und ihren Hauptsitz in Nikosia hat. Sie bieten Brokerage-Dienstleistungen innerhalb von Forex und CFDs an. Die operative Umsetzung basiert auf einer eigenen Plattform namens PROfit. Trotz lauter Aussagen, ein kundenbezogener Finanzassistent zu sein, sieht die Realität bei ihnen ganz anders aus. Nachfolgend erfahren Sie, welche Arten von FXGM-Bonusaktionen derzeit verfügbar sind.

FXCM Regulierungen

Da FXGM seinen Sitz in Zypern hat, unterliegt es der direkten Zuständigkeit der CySEC (Cyprus Securities and Exchange Commission) und ist ein registriertes CIF, Cyprus Investment Firm und ist unter der CIF-Lizenznummer 161/11 registriert. Das bedeutet auch, dass sie sich an die Vorschriften der MiFID (Markets in Financial Instruments Directive) des Europäischen Parlaments hält.

Zahlungsarten

FXGM akzeptiert Zahlungen nur per Banküberweisung und Kredit-/Debitkarte. Während sie die Arbeit erledigen, bevorzugen viele Menschen heutzutage andere Lösungen. E-Wallets wie Skrill sind eine beliebte Alternative, besonders wenn es um internationale Transfers geht.

Plattformen

Die große Auswahl an möglichen Handelsplattformen bei FXGM zieht viele verschiedene Arten von Händlern an.

Die immer beliebtere MT4-Plattform ist nach wie vor eine der am einfachsten zu bedienenden Plattformen und könnte wie bei vielen anderen Brokerhäusern für sich allein stehen.

Aber FXGM bietet auch andere Handelsplattformen an, darunter die WebPROfit- und PROfit-Plattformen, beides hochmoderne Handelsplattformen, die für Händler bei FXGM leicht verständlich und einfach zu bedienen sein sollten.

PROfit

Bei FXGM stehen 4 Plattformen zur Auswahl. Die PROfit-Plattform ist eine fortschrittliche Handelsplattform, die entwickelt wurde, um die Bedürfnisse und Anforderungen aller Trader zu erfüllen. Die PROfit-Plattform bietet erfahrenen Anwendern die fortschrittlichsten und professionellsten Tools.

WebPROfit

Mit WebPROfit ist das Handeln einfach und komfortabel. Sie können Devisen, Rohstoffe und CFDs handeln, ohne Software herunterladen zu müssen. Ein CFD ist ein Differenzkontrakt und ein derivatives Instrument. In einem Differenzvertrag vereinbaren ein Käufer und ein Verkäufer, dass der Verkäufer nach Ablauf des Vertrages dem Käufer die Differenz zwischen dem Wert des Vermögenswertes zum Zeitpunkt der Vertragsvereinbarung und dem Wert zum Zeitpunkt seines Ablaufs zahlt. Der CFD bietet die Möglichkeit, mit Leverage zu handeln und bietet dem Trader auch die Möglichkeit, das Risiko zu begrenzen.

Tags | Permalink | Kommentare deaktiviert für FXGM Erfahrungen 2019
Auto/Verkehr Finanzen/Wirtschaft Gesellschaft/Politik Pressemitteilungen

Automotive lightweight materials market is set to see healthy CAGR during 2018 to 2024

5. Juli 2019 – 19:16

Global Automotive Lightweight Materials Market size is estimated to grow at a double digit CAGR in the projected period due to increasing demand for improving safety and performance in vehicles along with enhancing fuel economy. Continuous upgradation of vehicles for complying to latest regulatory and compliance norms along with increasing focus of automobile manufacturers to offer highly efficient vehicles are expected to positively influence the industry share. Rising prevalence of electric vehicles along with the requirement for extending driving range of such vehicles are further boosting the industry size.

Stringent efficiency and emission norms are expected to provide a positive outlook for the automotive lightweight materials market expansion. The Corporate Average Fuel Economy (CAFE) standards mandate the automobile manufacturers to maintain a minimum standard fuel economy average of up to 55 miles per gallon. These are enabling automobile manufactures to invest in advanced and lightweight materials, thereby expanding the industry share.

Request for an in-depth table of contents for this report @  https://www.gminsights.com/request-toc/upcoming/3315

Based on vehicle, the automotive lightweight materials market share can be segmented into PCV, LCV, and HCV. PCV will account for a significant share over the projected timeframe. This can be attributed to the increasing vehicle production across the globe. Moreover, the rising preference for affordable and efficient means of personal transportation along with convenient financing and ownership schemes are expected to further boost the segment share.

Based on application, the automotive lightweight materials market size is classified into interior, exterior, powertrain, and structure. The interior segment is expected to grow significantly over the projected timeframe. This can be attributed to the increasing focus of automobile manufacturers to launch vehicles with premium interior experience. Moreover, the incorporation of advanced electronics and sensors in vehicle interiors for enhancing the passenger experience, along with improving vehicle performance are expected to boost the segment size.

The automotive lightweight materials market share based on materials can be classified into composites, metals, plastics, and rubber. Composites will exhibit considerable growth over the projected timeframe. This can be credited to the benefits offered by the material including lower weight, higher strength, and superior design flexibility. The enhanced corrosion resistance along with tighter tolerance limits are expected to further expand the segment size.

Make an inquiry for buying this report @  https://www.gminsights.com/inquiry-before-buying/3315

Asia Pacific will account for a significant share in the automotive lightweight materials market share. This can be attributed to the increasing demand for low cost and light weight compact vehicles across the region. The increasing demand for Kei cars in Japan and sub-four-meter vehicles in India are expected to further expand the regional share. Moreover, consumers across the region usually prefer vehicles with superior fuel economy, thereby enabling automobile manufacturers to invest in R&D for significantly lowering vehicle weight

Industry players are continuously investing in R&D for developing light weight vehicles for expanding the automotive lightweight materials market size. For instance, from 2016 to 2018, General Motors launched around 14 vehicle models with an overall weight reduction of around 5,000 pounds, thereby accounting to 350 pounds per vehicle. Additionally, major automobile manufacturers are continuously investing in a diversified range of materials including carbon fiber composites, aluminum, magnesium, along with a diversified range of plastics and foams for use in chassis, powertrain, and body structure.

The automotive lightweight materials market share is highly competitive owing to the presence of multiple industry players including Aleris International, Covestro LLC, Sabic group, Dow DuPont Inc, Kaiser Aluminium, US Magnesium LLC, Reliance Industries Limited, Nippon Fiber Graphite Corporation and Owens Corning Corporation. Industry players are engaged in strategic partnerships and joint ventures for boosting their market share. For instance, in January 2016, Saint Gobain entered into a strategic partnership with Corning for launching light weight automotive glass solutions.

Browse Full Reports: https://www.gminsights.com/industry-analysis/automotive-lightweight-materials-market

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Permalink | Kommentare deaktiviert für Automotive lightweight materials market is set to see healthy CAGR during 2018 to 2024
Finanzen/Wirtschaft

Dominic Rompf rückt in den Vorstand der Hüttig & Rompf AG auf

5. Juli 2019 – 14:08

Frankfurt am Main, den 5. Juli 2019 – Die Hüttig & Rompf AG erweitert ihren Vorstand. Seit 1. Juli verstärkt Dominic Rompf das Duo um Paul Hüttig und den neu gewählten Vorstandsvorsitzenden Ditmar Rompf. Es ist die erste Änderung im Vorstand, seitdem das Unternehmen vor 18 Jahren in eine AG umgewandelt wurde.

Der Vorstand des Frankfurter Baufinanzierers Hüttig & Rompf besteht künftig aus einem Trio. Neben den Unternehmensgründern Paul Hüttig und Ditmar Rompf gehört seit 1. Juli auch Dominic Rompf der Führungsebene an. Der bisherige Direktor für die Bereiche Schulung, IT und Filialbetrieb ist seit 1998 im Unternehmen. Es ist die erste Änderung im Vorstand, seitdem das Unternehmen vor 18 Jahren in eine AG umgewandelt wurde.

„Mit Dominic Rompf kommt ein langjähriger Kollege in den Vorstand, der Paul Hüttig und mich perfekt ergänzt. Von seinem technischen Know-how und seiner Erfahrung können wir profitieren“, erklärt Ditmar Rompf, der im Zuge der Vorstandserweiterung zum Vorstandsvorsitzenden gewählt wurde. Für Vorstandskollege Paul Hüttig führt Dominic Rompf eine Tradition fort: „Ein besonderes Zeichen unseres Unternehmens war es schon immer, dass Hüttig & Rompf inhabergeführt ist. So sind wir zu einem der erfolgreichsten Baufinanzierer Deutschlands geworden. Mit Dominic Rompf, dem Sohn von Ditmar Rompf, knüpfen wir an diese Stärke an.“

Dominic Rompf – Der IT-Chef erweitert den Vorstand

Dominic Rompf ist seit 21 Jahren im Team von Hüttig & Rompf. Er begann 1998 als Freiberufler in der Technik-Abteilung. Dort entwickelte er unter anderem die ersten Datenbanken des Unternehmens. Später leitete der gelernte Informatiker fünf Jahre lang die IT-Abteilung. Im Juli 2016 übernahm Dominic Rompf dann eine Führungsposition in der Frankfurter Zentrale. Als Direktor kümmerte er sich zuletzt um die Bereiche Schulung, IT und Filialbetrieb. Im neuen Vorstand liegt sein Schwerpunkt hauptsächlich auf den Themen IT, Technik und Personal. „Die Digitalisierung hat mittlerweile alle Lebensbereiche erreicht und auch großen Einfluss auf unsere Arbeit als Baufinanzierer. Ich freue mich, dieses wichtige Thema künftig als Vorstand bei Hüttig & Rompf weiter voranzutreiben“, sagt Dominic Rompf.

Download Bildmaterial: www.purepress.de/huettigrompf/HR-Dominic-Rompf-Vorstand.zip

Download PDF: www.purepress.de/huettigrompf/HR-PM-Dominic-Rompf-Vorstand.pdf

Über die Hüttig & Rompf AG

Die Hüttig & Rompf AG ist seit 1988 auf die Vermittlung von Baufinanzierungen spezialisiert. An 31 Standorten in ganz Deutschland beraten über 165 Experten Kunden in allen Fragen rund ums Kaufen, Bauen und Modernisieren. Dazu greifen die Berater auf einen Pool von 300 Partnerbanken und Sparkassen zurück. So konnte die Hüttig & Rompf AG in den letzten Jahren 60.000 Kunden den Traum von der eigenen Immobilie erfüllen.

Ihre Pressekontakte

Hüttig & Rompf AG

Jörg Weisenberger

Hanauer Landstraße 126-128

60314 Frankfurt

Tel: 069/907 46 66 0

marketing@huettig-rompf.de

 

Pure Perfection PR GmbH

Christopher Haacker

Strelitzer Straße 2

10115 Berlin

Tel: 030/400 53 53 0

ch@pureperfection.com

Tags | Permalink | Kommentare deaktiviert für Dominic Rompf rückt in den Vorstand der Hüttig & Rompf AG auf
Finanzen/Wirtschaft Pressemitteilungen

Colposcopy Market for Rapid Growth and Trend by 2023

5. Juli 2019 – 13:57

The colposcopy market is expected to reach USD 740.1 Million by 2023 from USD 498.8 Million in 2017 at a CAGR of 6.8% during the forecast period. The base year for this study is 2017 and the forecast period is 2018–2023.

Read More @ https://www.marketsandmarkets.com/PressReleases/colposcopy.asp

Top Key Players

The key players in the Colposcopy market include DySIS (US), CooperSurgical (US), Atmos (Germany), Olympus (Japan), Karl Kaps (Germany), McKesson (US), Danaher (US), and Carl Zeiss (Germany)

Market growth can largely be attributed to factors such as the heavy burden of cervical cancer, the rapidly growing geriatric population, and technological advancements in colposcopy. Increasing awareness about gynecological diseases and the emerging Asian markets are expected to present a wide array of growth opportunities for players in the market.

Browse 62 Tables and 31 Figures spread through 116 Pages and in-depth TOC on „Colposcopy Market“

Target Audience for this Report:

  • Manufacturers and vendors of colposcopy
  • Research associations related to cervical cancer
  • Various research and consulting firms
  • Distributors of colposcopy  products
  • Contract manufacturers of colposcopy  products
  • Healthcare institutions
  • Research institutes

The global market is dominated by North America, followed by Europe. North America will continue to dominate the global market in the forecast period. However, Asia is expected to witness the highest CAGR. The large share of the North American Market can primarily be attributed to the high burden of cervical cancer, increasing government initiatives, availability of technologically advanced screening tools, the presence of major players in this region, and the presence of quality healthcare infrastructure.

While the colposcopy market offers lucrative growth opportunities to key players, the availability of alternative methods is expected to limit market growth during the forecast period. The lack of skilled clinical professionals may also challenge market growth to a certain extent.

Know More About Key Industry Players @ https://www.marketsandmarkets.com/ResearchInsight/colposcopy-market.asp

 

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledgestore“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

 

Tags , | Permalink | Kommentare deaktiviert für Colposcopy Market for Rapid Growth and Trend by 2023
Finanzen/Wirtschaft Gesundheit/Medizin Pressemitteilungen Wissenschaft/Forschung

Investoren setzen auf Phagentherapie: Lösungsansatz für die Antibiotika-Krise mit zusätzlichem Millionenbetrag finanziert

27. Juni 2019 – 10:31

Wien, 27. Juni 2019: Das Wiener Biotech-Unternehmen PhagoMed Biopharma GmbH gab heute den Abschluss einer weiteren Finanzierungsrunde bekannt. Das am Vienna Biocenter angesiedelte Unternehmen befasst sich mit der Entwicklung von Phagen-basierten Arzneimitteln. Für diese werden spezielle Viren (Phagen) zur Behandlung von multiresistenten bakteriellen Infektionen eingesetzt. Der vielversprechende Lösungsansatz im Kampf gegen die Antibiotika-Krise war privaten Investoren nun weitere EUR 1,5 Millionen an Investments wert, die vom Unternehmen zur Gänze in die weitere Entwicklung dreier Arzneimittelkandidaten investiert werden.

 

Die PhagoMed Biopharma GmbH (PhagoMed) arbeitet an Lösungsansätzen für die weltweite Antibiotika-Krise, der Zunahme von Resistenzen gegen diese einst so wirksamen Therapeutika. Das Unternehmen entwickelt dazu Arzneimittel auf Basis von natürlichen Viren, die ausschließlich Bakterien befallen und zerstören, sogenannten Phagen. Auf Grund ihrer Fähigkeit, Bakterien gezielt zu zerstören, bieten sie einen vielversprechenden Ansatz, um für multiresistente Infektionen neue Heilungsmöglichkeiten zu schaffen. So gelang es Mitgründern von PhagoMed bereits, Phagen im Rahmen von experimentellen Heilversuchen in Deutschland erfolgreich anzuwenden.

 

Schon letztes Jahr konnte PhagoMed mehr als EUR 4 Millionen an privaten Investments und öffentlichen Förderungen einwerben und die Forschungsaktivitäten am Vienna Biocenter aufnehmen. Das Unternehmen gab nun weitere Investments in Höhe von EUR 1.5 Millionen bekannt, die von bestehenden und neuen Investoren zur Verfügung gestellt wurden.

 

„Seit Aufnahme der Forschungsaktivitäten im Mai 2018 konnten wir bereits konkrete Arzneimittelkandidaten identifizieren und validieren diese derzeit in Tierstudien. Die bisher gewonnenen Ergebnisse überzeugten unsere bestehenden und neuen Investoren davon, unsere F&E mit zusätzlichen Mitteln zu forcieren“, berichtet PhagoMed Mitgründer und Ko-Geschäftsführer Alexander Belcredi. „Die zusätzlichen Seed-Investments erlauben uns nun das Team weiter aufzustocken und wichtige Investitionen in unsere Infrastruktur vorzunehmen.“

 

Als besonders vielversprechend erachtet die Firma den Einsatz von Phagen zur Behandlung infizierter künstlicher Gelenke wie z.B. Hüftprothesen. Infektionen dieser millionenfach eingesetzten Prothesen sind bereits heute schwer zu behandeln, da diese häufig von multiresistenten Bakterien verursacht werden. Diese bilden zudem oftmals einen als Biofilm bezeichneten Belag, der die Wirkung von Antibiotika zusätzlich reduzieren kann. Gerade bei solchen Infektionen stellen Phagen eine vielversprechende Alternative dar, da Phagen in der Lage sind, bakterielle Biofilme abzubauen und dabei die multiresistenten Bakterien zu töten. Einer der drei vom Unternehmen identifizierten Arzneimittelkandidaten zielt genau auf diese Anwendung ab und wird derzeit in Tierstudien evaluiert. Den Beginn erster klinischer Studien zur Behandlung Implantat-assoziierter Infektionen plant PhagoMed für das Jahr 2021.

 

 

Über PhagoMed Biopharma GmbH
PhagoMed Biopharma GmbH ist ein auf die Entwicklung von zugelassenen humantherapeutischen Anwendungen der Phagentherapie spezialisiertes Biotech-Unternehmen. Aktuell arbeitet PhagoMed an drei Entwicklungsprogrammen in drei verschiedenen Indikationen: Implantat-assoziierte Infektionen, Harnwegsinfektionen und bakterielle Vaginose. Diese Programme basieren sowohl auf den Behandlungserfahrungen der klinischen Mitgründer mit Phagen im Rahmen von experimentellen Heilversuchen als auch auf Forschungskollaborationen mit hochrenommierten Wissenschaftern und Forschungseinrichtungen in Deutschland (Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig sowie Justus-Liebig-Universität Gießen) und Belgien (Universität Ghent). Seit Gründung im November 2017 hat die Firma mehr als €5,5 Millionen an öffentlichen Förderungen und privaten Investments eingeworben. PhagoMed wird unter anderem von der Österreichischen Forschungsförderungsgesellschaft mbH (FFG) sowie der Austria Wirtschaftsservice Gesellschaft mbH (aws) unterstützt. Derzeit arbeiten 11 hochqualifizierte Wissenschafter an den Entwicklungsprogrammen, darunter sechs Mitarbeiter am Campus Vienna Biocenter in Wien.

 

Über Phagen
Phagen sind Viren, die ausschließlich Bakterien befallen. Phagen vermehren sich, indem sie Bakterien mit ihrer DNA infizieren und dann die Bakterienzelle zur Herstellung neuer Phagen umprogrammieren. Sobald ausreichend neue Phagen produziert wurden, zerstören die Phagen mittels eigens produzierter Enzyme die Bakterienzellwände und führen so zum Zelltod. Individuelle Phagen wirken nur gegen ein sehr eingeschränktes Spektrum an Bakterien (typischerweise nur innerhalb einer Spezies). Diese Kombination aus hoher Selektivität und gleichzeitig hoher Effektivität in der Tötung von Bakterien macht Phagen zu einer hochinteressanten Alternative zu Antibiotika bei der Behandlung bakterieller Infektionen.

 

 

Rückfragehinweis:

Kontakt PhagoMed
Alexander Belcredi
PhagoMed Biopharma GmbH
Goldeggasse 6, Top 5-6
1040 Wien
E alexander.belcredi@phagomed.com
W www.phagomed.com

Redaktion & Aussendung
PR&D – Public Relations
für Forschung & Bildung
Dr. Barbara Bauder
Mariannengasse 8
1090 Wien
T +43 / 1 / 505 70 44
E bauder@prd.at
W http://www.prd.at/

Tags , , | Permalink | Kommentare deaktiviert für Investoren setzen auf Phagentherapie: Lösungsansatz für die Antibiotika-Krise mit zusätzlichem Millionenbetrag finanziert
Computer/Internet/IT Finanzen/Wirtschaft Pressemitteilungen

Global Healthcare Business Intelligence Market worth $8.9 billion by 2023

18. Juni 2019 – 13:15

The healthcare business intelligence market is expected to reach USD 8.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 15.3% during the forecast period.

Read More @ https://www.marketsandmarkets.com/PressReleases/healthcare-business-intelligence-bi.asp

The study involved four major activities to estimate the current size of the market. Exhaustive secondary research was done to collect information on the market, its peer markets, and its parent market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Top Key Players

The healthcare business intelligence market is highly competitive, with the presence of both large and small players. Microsoft (US), IBM (US), Oracle (US), SAP SE (Germany), SAS Institute Inc. (US), Tableau Software (US), MicroStrategy Incorporated (US), QlikTech International AB (US), Information Builders (US), Sisense Inc. (US), Yellowfin BI (Australia), and BOARD International (Switzerland) are some of the leading payers in healthcare business intelligence market.

Browse 150 market data Tables

40 Figures 

194 Pages and in-depth TOC on „Healthcare Business Intelligence Market„

Recent Developments

  • In 2018, Oracle acquired Zenedge (US) to secure critical IT systems deployed via cloud, on-premise, or hybrid hosting environments with the help of Zenedge.
  • In 2018, SAS entered into an agreement with Deloitte (Canada) to support their existing strategic alliance that will leverage their combined expertise to introduce lower-risk and higher-quality outcomes in the insurance marketplace.
  • In 2017, Microsoft partnered with SAP SE (Germany) to drive more business innovation in the cloud and provide joint support services to ensure the best cloud experience for customers.

The market is dominated by North America, followed by Europe, Asia, and RoW. The market in North America is expected to witness the highest growth during the forecast period. The high growth of the North American market can be attributed to the increasing adoption of healthcare intelligence solutions and services by healthcare providers (especially in the US) to provide better quality care and lower healthcare costs is a major factor driving market growth.

Know more about key industry players @ https://www.marketsandmarkets.com/ResearchInsight/healthcare-business-intelligence-market.asp

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledgestore“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Tags , | Permalink | Kommentare deaktiviert für Global Healthcare Business Intelligence Market worth $8.9 billion by 2023
Computer/Internet/IT Finanzen/Wirtschaft Pressemitteilungen

Bowel Management Systems Market 2019 | Business Overview | 2023

18. Juni 2019 – 12:09

The global bowel management systems market is expected to reach USD 2.07 billion by 2023 from USD 1.68 billion in 2017, at a CAGR of 3.5%.

Read More @ https://www.marketsandmarkets.com/PressReleases/bowel-management-system.asp

Growth in the bowel management systems market is mainly driven by factors such as the expanding target patient population, the rapidly growing geriatric population, availability of technologically advanced bowel management products, and the favorable reimbursement scenario in developed countries.

An analysis of market developments between 2015 and 2018 revealed that growth strategies such as product launches and approvals, agreements, expansions, and acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the bowel management systems market. Among these, product launches and approvals were the most widely adopted growth strategies

Top Key Players 

As of 2017, the various product segments considered in the bowel management systems market was dominated by Coloplast (Denmark), Medtronic (Ireland), Hollister (US), and ConvaTec (UK). These companies accounted for a majority of the share in the global bowel management systems market in 2017.

Browse 61 market data Tables

31 Figures

120 Pages and in-depth TOC on „Bowel Management Systems Market„

The report covers the bowel management systems market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). Europe is expected to command the largest share of the market in 2018. The strong market position of Europe in the bowel management systems market is mainly due to the significant colorectal/bladder cancer & IBD disease burden, favorable reimbursement scenario, and the increase in its geriatric population.

Stakeholders

  • Bowel management product manufacturers
  • Ostomy care bag manufacturers
  • Third-party product suppliers and distributors
  • Retail pharmacies and other off-the-shelf sales channels
  • Raw material suppliers
  • Market research and consulting firms
  • National & international regulatory bodies
  • Venture capitalist firms
  • Hospitals & other healthcare providers

Know more about key industry players @ https://www.marketsandmarkets.com/ResearchInsight/bowel-management-system-market.asp

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledgestore“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

 

Tags , | Permalink | Kommentare deaktiviert für Bowel Management Systems Market 2019 | Business Overview | 2023
Finanzen/Wirtschaft Pressemitteilungen

Global Atherectomy Devices Market is Projected to Reach $1.45 Billion by 2022

18. Juni 2019 – 11:22

The global atherectomy devices market accounted is projected to reach USD 1.45 Billion by 2022 from USD 1.02 Billion in 2016, at a CAGR of 6.1% during the forecast period.

Read More @ https://www.marketsandmarkets.com/PressReleases/atherectomy-devices.asp

Factors such as favorable reimbursement scenario for atherectomy procedures, increasing number of research activities in the field of atherectomy, and increasing healthcare expenditure are driving the growth of the market.

The report studies the global atherectomy devices market over the forecast period of 2017 to 2022.

Top Key Players 

In 2016, Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), and Cardiovascular Systems (US) held the leading position in the global atherectomy devices market. In the past three years, these companies adopted product launches, strategic acquisitions, mergers, agreements, collaborations, and expansions as their key business strategies to ensure market dominance. Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US) are some of the other major players in this market.

Stakeholders

  • Original equipment manufacturers (OEMs)
  • Product sales and distribution companies
  • Healthcare service providers (hospitals and surgical centers)
  • Non-government organizations
  • Government regulatory authorities
  • Research laboratories and academic institutes
  • Clinical research organizations (CROs)
  • Research and development companies
  • Market research and consulting firms

This report covers the atherectomy devices market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). Of the four geographic regions studied in the report, North America is expected to command the largest share of the market in 2017.

Factors such as increasing availability of reimbursements for atherectomy systems, growing adoption of atherectomy systems among medical professionals, large patient population of peripheral & coronary artery diseases, and growing number of clinical trials (that aim to evaluate the therapeutic efficacy of atherectomy systems in specific disease treatment) are driving the growth of the North American atherectomy devices market.

Stakeholders

  • Original equipment manufacturers (OEMs)
  • Product sales and distribution companies
  • Healthcare service providers (hospitals and surgical centers)
  • Non-government organizations
  • Government regulatory authorities
  • Research laboratories and academic institutes
  • Clinical research organizations (CROs)
  • Research and development companies
  • Market research and consulting firms

Know more about key industry players @ https://www.marketsandmarkets.com/ResearchInsight/atherectomy-devices-market.asp

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledgestore“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Tags , , | Permalink | Kommentare deaktiviert für Global Atherectomy Devices Market is Projected to Reach $1.45 Billion by 2022
Finanzen/Wirtschaft Pressemitteilungen

Future of Point of Care Molecular Diagnostics Market In Next 5 Years

17. Juni 2019 – 11:17

The global point of care molecular diagnostics market was valued at USD 632.5 Million in 2017 and is projected to reach USD 1,440.2 Million in 2023, at a CAGR of 14.7%.

Read More @ https://www.marketsandmarkets.com/PressReleases/point-of-care-molecular-diagnostic.asp

Growth in the point-of-care (POC) molecular diagnostics market is mainly driven by factors such as the increasing worldwide prevalence of infectious diseases, rising focus on decentralized diagnostics, and the growing demand for CLIA-waived molecular POC tests.

Top Key Players

Some of the key players in the global POC molecular diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Biomerieux SA (France), and Danaher (US). Product development was the major strategy adopted by these major players to maintain their leadership position in the global POC molecular diagnostics market.

Browse 68 market data Tables 

23 Figures

106 Pages and in-depth TOC on „Point of Care Molecular Diagnostics Market„

In this report, the market has been categorized based on product & service, applications, technology, end user, and region.

Target Audience:

  • POC Molecular Diagnostics Manufacturers
  • Physicians
  • Research Institutes
  • Diagnostics Suppliers
  • Market Research and Consulting Firms
  • Regulatory Bodies
  • Venture Capitalists

In 2018, North America is expected to account for the largest share of the global POC molecular diagnostics market. The growing prevalence of infectious diseases, increasing number of CLIA product approvals, and rising government initiatives to support the adoption of POC molecular diagnostics in this region are driving the market growth.

Know more about key industry players @ https://www.marketsandmarkets.com/ResearchInsight//point-of-care-molecular-diagnostic-market.asp

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledgestore“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Tags , | Permalink | Kommentare deaktiviert für Future of Point of Care Molecular Diagnostics Market In Next 5 Years

Nächste Seite »

Nächste Seite »